2013-2018 depth investigation and investment prospects of China's anti-inflammatory drugs market study report number (No.): 124482 Research Institute of China research in the business [Keywords: anti-inflammatory drugs prediction / research / analysis Publication Date: May 2013 [ delivery method: an electronic version or EMS [Price]: [paper version]: 6500 yuan [electronic version]: 6800 yuan [bound]: 7000 yuan [Order by phone: 010-56188198 [green channel]: 15313583580 【QQ Consulting】: 1,797,100,025,775,829,479 [Contact: Gao Hong website link: http://www.hyzsyjy.com/report/124482.html (click to enter the body of the website) [Report Contents] anti-inflammatory drug-related overview of the first anti-inflammatory drugs basic brief, the mechanism of anti-inflammatory drugs medicinal characteristics and efficacy of anti-inflammatory drugs, anti-inflammatory drugs clinical application of the principles of Section II anti-inflammatory drugs category standards and commonly used anti-inflammatory drug that describes an anti-inflammatory drugs type of standard, non-steroidal and steroidal - glucocorticoids, commonly used anti-inflammatory drug that elaborate, penicillins, cephalosporins 3, aminoglycosides, macrolides 5 , tetracyclines, quinolones, sulfonamides, other Section III anti-inflammatory drugs and antibiotics in the fourth quarter anti-inflammatory drugs and antibacterials Chapter II of the 2012 World anti-inflammatory drugs overall operation of the situational analysis of the first section of the 2012 World anti-inflammatory drugs industry Summary of development, the world market for anti-inflammatory drugs dynamic analysis, development and trends of foreign non-steroidal anti-inflammatory drugs, the world's anti-inflammatory drugs Technical Analysis Section II in 2012 in the major regions of the world anti-inflammatory drugs industry analysis, industry analysis of U.S. anti-inflammatory drugs , the European anti-inflammatory drugs industry analysis, anti-inflammatory drugs industry in Asia, India's anti-inflammatory drugs industry analysis Section III 2013-2018 World anti-inflammatory drugs industry development trend analysis Chapter 2012 Chinese anti-inflammatory drugs industry operating environment analysis Section I in 2012, China's macroeconomic environment, the operation of the national economy (updated quarterly) GDP, consumer price index CPI, PPI (monthly update), the national household income (updated quarterly) Fourth, the Engel coefficient (annual Section II of the update), industrial development situation (updated quarterly) Sixth, investment in fixed assets (updated quarterly) 7, total retail sales of social consumer goods VIII, foreign trade, import & export of nine, the pharmaceutical industry's position in the national economy 2012 anti-inflammatory drugs industry policy environment analysis, China's medical and health system, anti-inflammatory drugs standard three Chinese pharmaceutical import and export policies of the third quarter 2012 Chinese anti-inflammatory drugs industry social environment analysis, the scale of China's population, the Chinese health care spending expenditures, people's consumption concept Chapter 2012 Chinese anti-inflammatory drugs industry status quo analysis of the first 2012 Summary of the industrial development of China's anti-inflammatory drugs, anti-inflammatory drugs stage of development, China's industrial structure analysis of anti-inflammatory drugs, anti-inflammatory drug research progress Section II 2012 Chinese industrial production of anti-inflammatory drugs, anti-inflammatory drugs production principle, anti-inflammatory drugs production process, the role and use of anti-inflammatory drugs the third quarter 2012 Chinese anti-inflammatory drugs industry development problems in Chapter 2012 anti-inflammatory drugs industry market dynamics analysis Section I 2012 Chinese anti-inflammatory drugs market situation analysis, the scale of anti-inflammatory drugs in the analysis, anti-inflammatory drugs retail market sales, the amount of hospital anti-inflammatory medicinal Section II 2012 Chinese anti-inflammatory drugs market price analysis , anti-inflammatory drugs market price factors, anti-inflammatory drugs market price trend of the third quarter of 2012, China's anti-inflammatory drug industry marketing analysis Chapter VI of the fourth quarter 2012 analysis of China's anti-inflammatory drug industry marketing strategies 2007-2012 anti-inflammatory drugs manufacturing industry data monitoring and analysis Section 1 2007-2012 China anti-inflammatory drugs manufacturing industry scale analysis, enterprise growth in the number of analysis, number of employees grew analysis, asset size growth analysis Section II 2012 Chinese anti-inflammatory drugs manufacturing industry structure analysis the number of firms structural analysis, different types of analysis, the different forms of ownership, sales revenue structure, different types of analysis, different forms of ownership analysis Section III 2007-2012 manufacturing industry output value of China's anti-inflammatory drugs, finished goods increased analysis, industrial sales output value, export delivery value analysis the fourth 2007-2012 anti-inflammatory drugs manufacturing industry cost analysis, cost of sales statistics, the Costs section V 2007-2012 Chinese anti-inflammatory drugs manufacturing industry Profitability Analysis, the main profitability indicators, the main profitability indicators analysis of Chapter VII of the 2012 Chinese anti-inflammatory drugs hot products market first section aspirin pharmaceutical ingredients and medication principles, efficacy and side effects, clinical application case, the market sales analysis, price analysis six consumer evaluation section II of acetaminophen (paracetamol), the Section III diclofenac fourth quarter indomethacin (indole indomethacin) Section V ibuprofen Section VI fenbufen Section 7 Andrographis lactone pills Section IX cephalosporin Section VIII hormone drugs anti-inflammatory drugs Chapter VIII of the 2006-2011 anti-inflammatory drugs market and export data analysis of the first 2006-2011 penicillin V Import and Export Statistics (29411094), penicillin V number of import and export, import and export analysis of the amount of penicillin V, penicillin V import and export countries and regions analysis Section II 2006-2011 China ceftriaxone (ceftriaxone) into the export overall data (30,032,017), cephalosporins triazine (ceftriaxone) the number of import and export analysis, ceftriaxone (ceftriaxone) the amount of import and export analysis, ceftriaxone (ceftriaxone) import and export countries and regions analysis Section III 2006-2011 erythromycin and its derivatives, salt overall import and export data (29415000), erythromycin and its derivatives, salt import and export volume, erythromycin and its derivatives, salt import and export analysis of the amount, erythromycin and its derivatives, salt exporting and importing countries and regions the fourth 2006-2011 Acetylspiramycin and its derivatives overall import and export data (29,419,070), Acetylspiramycin and its derivatives the number of import and export analysis, Acetylspiramycin and its derivatives import and export analysis of the amount Acetylspiramycin and its derivatives import and export countries and regions analysis Section V 2006-2011 gentamicin and its derivatives, salt overall import and export data (29,419,010), gentamicin and its derivatives, salt, Import and Export quantitative analysis of gentamicin and its derivatives, the amount of salt import and export analysis, gentamicin competition in the industry status quo of China's anti-inflammatory drugs and their derivatives, salts exporting and importing countries and regions Chapter 2012 Chinese anti-inflammatory drugs industry market competition analysis Section I 2012 analysis of the degree of competition in the industry of anti-inflammatory drugs, anti-inflammatory drug companies competitiveness of domestic anti-inflammatory drugs proposed projects under construction the second in 2012, the Chinese anti-inflammatory drugs industry competition pattern analysis, market concentration of anti-inflammatory drugs, anti-inflammatory drugs main varieties of potential competition analysis, the potential anti-inflammatory Drug kinds of competition analysis Section III 2013-2018 China anti-inflammatory drugs enterprises to enhance their competitive strategy analysis Chapter 2012 Chinese anti-inflammatory drugs focus on the competitiveness of enterprises comparative analysis (Enterprise can be optional) the first section Shijiazhuang Pharmaceutical Group Co., Ltd., enterprises Overview, major economic indicators of analysis, profitability analysis, corporate solvency analysis, the ability of business operations analysis, corporate growth capacity analysis Section II Zhuhai United Laboratories Co., Ltd. Company Profile enterprises are mainly analysis of economic indicators, profitability analysis, corporate solvency analysis, the ability of business operations business growth ability analysis of the third quarter of Hunan Zhongnan Pharmaceutical Co., Ltd. Company Profile, major economic indicators of analysis, profitability analysis, corporate solvency analysis, the ability of business operations analysis business growth Analysis Section IV Harbin Pharmaceutical Group Co., Ltd. Company Profile Second, the major economic indicators of analysis, profitability analysis, corporate solvency analysis, the ability of business operations analysis, corporate growth Analysis Section V Holley South Lake, Zhejiang Pharmaceutical Co., Ltd. Company Profile Second, the major economic indicators of analysis, profitability analysis, corporate debt service the ability to analyze the ability of business operations, corporate growth Analysis Section VI North China Pharmaceutical Co., Ltd. Qinhuangdao, Company Profile Second, the major economic indicators of analysis, profitability analysis, corporate solvency analysis, business operations Analysis business growth Analysis Section VII Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Company Profile, major economic indicators of analysis, profitability analysis, corporate solvency analysis, the ability of business operations analysis of six, Business Growth Analysis Section VIII Kunming Baker Norton Pharmaceutical Co., Ltd. Company Profile Second, the major economic indicators of analysis, the profitability of the business analysis, corporate solvency analysis, the ability of business operations business growth ability analysis of the first nine Shanghai Huayuan Anhui Renji Pharmaceutical Co., Ltd., Company Profile, major economic indicators of analysis, profitability analysis, corporate solvency analysis, the ability of business operations analysis business growth Analysis Section X Hunan Li Wei Li Wei Pharmaceutical Co., Ltd. Company Profile Second, major economic indicators of analysis, profitability analysis, corporate solvency analysis, enterprise operators the ability to analyze the business growth ability XI Abridged ...... Chapter 2013-2018 Chinese anti-inflammatory drugs industry trends predictive analysis Section I 2013-2018 China's pharmaceutical industry trends analysis, the country's pharmaceutical market development direction of Chinese pharmaceutical industry development trend analysis of China pharmaceutical industry competition analysis Section II 2013-2018 China anti-inflammatory drugs industry market trend analysis, market supply of anti-inflammatory drugs, anti-inflammatory drugs market demand forecast, market space for development of anti-inflammatory drugs 3 2013-2018 Forecast and Analysis anti-inflammatory drugs industry market profit forecast analysis of Chapter XII 2013-2018 anti-inflammatory drugs industry investment opportunities and risk analysis of the first 2012 Chinese anti-inflammatory drugs industry investment environment analysis Section II 2013-2018 China anti-inflammatory drugs industry investment opportunity to analyze the potential for investment analysis, regional investment hot spot analysis Section III 2013-2018 China's anti-inflammatory drugs industry investment risk analysis, market competition, risk analysis, policy risk, technology risk analysis, the exit risk analysis first The four Research Center experts suggest Chart Abstract: Chart :2005-2012 China's GDP growth trend chart: 2012 monthly CPI, PPI index chart Chart :2005-2012 China's urban residents' disposable income growth trends Chart :2005-2012 China's rural residents per capita net income growth trends Chart :1978-2010 China's urban and rural residents Engel coefficient Graph chart :2010.12 2012.12 China's industrial added value growth statistics chart :2005-2012, China's total fixed investment Graph Chart :2005-2012 China's total retail sales growth trends Chart :2005-2012 China's total import and export of goods Graph Chart :2005-2012 (2012 excluding farmers) of total imports and exports of Chinese goods Total Graph Chart :2007-2012 China's anti-inflammatory drugs the number of manufacturing industries and enterprises growth trends Chart :2007-2012 China's anti-inflammatory drugs manufacturing industry growth in the number of loss-making enterprises trend chart :2007-2012, China's anti-inflammatory drugs manufacturing industry growth in the number of The trend chart :2007-2012 China's anti-inflammatory drugs manufacturing industry asset size growth trend chart: in 2012, China's anti-inflammatory drugs manufacturing industry the number of different types of enterprises distribution chart: distribution of anti-inflammatory drugs manufacturing industry in 2012 the number of enterprises of different ownership chart: 2012 China's anti-inflammatory drugs manufacturing different types of enterprise sales income distribution chart: in 2012 China's anti-inflammatory drugs manufacturing industry enterprises of different ownership sales income distribution chart :2007-2012 China's anti-inflammatory drugs manufacturing industry finished goods growth trend chart: 2007 - 2012 China's anti-inflammatory drugs manufacturing industry output value of industrial sales growth trend chart :2007-2012 China's anti-inflammatory drugs manufacturing industry export delivery value growth trends Chart :2007-2012 China's anti-inflammatory drugs manufacturing cost of sales growth trend chart: 2007 -2012 China's anti-inflammatory drugs cost of manufacturing industry chart Chart :2007-2012 China's anti-inflammatory drugs manufacturing industry profitability indicators charts chart :2007-2012 main profitability indicators of China's anti-inflammatory drugs manufacturing industry growth trends Chart :2006-2011 penicillin V, the number of import and export analysis chart :2006-2011 China's import and export of penicillin V analysis of the amount of chart :2006-2011 Chinese penicillin V import and export average unit price analysis chart :2006-2011 Chinese penicillin V exporting and importing countries and regions analysis Chart :2006-2011 China ceftriaxone (ceftriaxone) the number of import and export analysis chart :2006-2011 China ceftriaxone (ceftriaxone) the amount of import and export analysis chart :2006-2011 Chinese ceftriaxone (cephalosporins ceftriaxone) import and export average unit price analysis chart :2006-2011 Chinese ceftriaxone (ceftriaxone) import and export countries and regions analysis chart :2006-2011, erythromycin and its derivatives, salt import and export volume analysis chart :2006-2011 erythromycin and its derivatives, salt, the amount of import and export analysis chart :2006-2011, erythromycin and its derivatives, salt import and export average unit price analysis chart :2006-2011 Chinese erythromycin and its derivatives, salt import and export countries and regions analysis chart :2006-2011 the China Acetylspiramycin and its derivatives the number of import and export analysis chart :2006-2011 of China Acetylspiramycin and its derivatives import and export analysis of the amount chart :2006-2011 of China Acetylspiramycin and its derivatives import and export average unit price analysis chart :2006-2011 of China Acetylspiramycin and its derivatives import and export countries and regions analysis chart :2006-2011 Chinese big celebration ADM and its derivatives, salt import and export volume analysis chart :2006-2011 gentamicin and its derivatives, salt amount of import and export analysis chart :2006-2011 Chinese gentamicin and its derivatives, salt import and export average unit price analysis chart :2006-2011 gentamicin and its derivatives, salt import and export countries and regions analysis chart: Shijiazhuang Pharmaceutical Group Co., Ltd. Main Economic Indicators Chart Chart: Shijiazhuang Pharmaceutical Group Co., Ltd. operating income trend Chart: Shijiazhuang Pharmaceutical Group Co., Ltd. profitability indicators Graph chart: Shijiazhuang Pharmaceutical Group Co., Ltd. and liabilities Chart: Shijiazhuang Pharmaceutical Group Co., Ltd. indicators debt Graph chart: Shijiazhuang Pharmaceutical Group Co., Ltd. operational capability indicators Graph chart: CSPC Limited ability to grow indicators Graph chart: Zhuhai United Laboratories Co., Ltd. Main Economic Indicators Chart Chart: Zhuhai United Laboratories Co., Ltd. operating income Chart Chart: Zhuhai the Federal Pharmaceutical Co., Ltd. Earnings Index Chart Chart: Zhuhai United Laboratories shares Limited liabilities Chart: Zhuhai United Laboratories Co., Ltd. liabilities indicators Chart Chart: Zhuhai United Laboratories Co., Ltd. operational capability indicators Graph chart: Zhuhai United Laboratories Co., Ltd. the ability to grow indicators Graph chart: Hunan Zhongnan Pharmaceutical Co., Ltd. The main economic indicators Graph chart: Hunan Zhongnan Pharmaceutical Co., Ltd. operating income Graph chart: Hunan Zhongnan Pharmaceutical Co., Ltd. Earnings Index Chart Chart: Hunan Zhongnan Pharmaceutical Co., Ltd. and liabilities Chart: Hunan Zhongnan Pharmaceutical Co., Ltd. liabilities indicators Chart Chart: Pharmaceutical Co., Ltd. in Hunan, China and South Africa operational capability indicators Graph chart: Hunan Zhongnan Pharmaceutical Co., Ltd. the ability to grow Index Chart Chart: Harbin Pharmaceutical Group Co., Ltd. Main Economic Indicators Chart Chart: Harbin Pharmaceutical Group Co., Ltd. operating income Graph chart: Harbin Pharmaceutical Group Co., Ltd. Earnings Index Chart Chart: Harbin Pharmaceutical Group Co., Ltd. and liabilities Chart: Harbin Pharmaceutical Group Co., Ltd. liabilities Index Chart Chart: Harbin Pharmaceutical Group Co., Ltd. operational capability indicators Graph chart: Hayao Group Limited ability to grow Index Chart Chart: Zhejiang Holley South Lake Pharmaceutical Co., Ltd. Main Economic Indicators Chart Chart: Holley South Lake, Zhejiang Pharmaceutical Co., Ltd. operating income Chart Chart: Holley South Lake, Zhejiang Pharmaceutical Co., Ltd. trend of profitability indicators Chart: Holley South Lake, Zhejiang Pharmaceutical Co., Ltd. and liabilities Chart: Zhejiang Holley South Lake Pharmaceutical Co., Ltd. liabilities indicators Graph chart: Zhejiang Holley South Lake Pharmaceutical Co., Ltd. operational capability indicators Graph chart: Zhejiang Holley South Lake Pharmaceutical Co., Ltd. the ability to grow indicators Graph chart: North China Pharmaceutical Co., Ltd. Qinhuangdao major economic indicators Chart Chart: North China Pharmaceutical Co., Ltd. Qinhuangdao operating income Chart Chart: North China Pharmaceutical Co., Ltd. Qinhuangdao profitability indicators Chart Chart: North China Pharmaceutical Co., Ltd. Qinhuangdao liabilities case charts: North China Pharmaceutical Qinhuangdao Co., Ltd. liabilities indicators Graph chart: North China Pharmaceutical Co., Ltd. Qinhuangdao operational capability indicators Chart Chart: North China Pharmaceutical Qinhuangdao Limited ability to grow Index Chart Chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. The main trend of economic indicators Chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. operating income trend chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. profitability indicators Chart Chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. and liabilities Chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. liabilities indicators Graph chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. operational capability indicators Graph chart: Guangzhou Baiyunshan Pharmaceutical Co., Ltd. the ability to grow Index Chart Chart: Kunming Baker Norton Pharmaceutical Co., Ltd. Main Economic Indicators Chart Chart: Kunming Baker Norton Pharmaceutical Co., The Company's operating income trend chart: Kunming Baker Norton Pharmaceutical Co., Ltd. profitability indicators Graph chart: Kunming Baker Norton Pharmaceutical Co., Ltd. and liabilities Chart: Kunming Baker Norton Pharmaceutical Co., Ltd. liabilities indicators Graph chart: Kunming Baker Norton Pharmaceutical Co., Ltd. operational capability indicators Graph chart: Kunming Baker Norton Pharmaceutical Co., Ltd. the ability to grow indicators Chart Chart: Shanghai Huayuan Anhui Renji Pharmaceutical Co., Ltd. Main Economic Indicators Chart Chart: the Shanghai Huayuan Pharmaceutical Co., Ltd. Anhui Renji operating income Chart chart: Huayuan Pharmaceutical Co., Ltd. Anhui Renji profitability indicators Graph chart: Shanghai Huayuan Pharmaceutical Co., Ltd. Anhui Renji liabilities Chart: Shanghai Huayuan Anhui Renji Pharmaceutical Co., Ltd. and liabilities indicators Graph chart: the Shanghai Huayuan Anhui Renji Pharmaceutical Limited operational capability indicators Graph chart: Shanghai Huayuan Pharmaceutical Co., Ltd. Anhui Renji ability to grow Index Chart Chart: Li Wei Pharmaceutical Co., Ltd. Hunan Li Wei Li Wei Pharmaceutical Co., Ltd. Main Economic Indicators Chart Chart: Hunan Liwin Group operating income trend chart: Hunan Liwin Group the Li Wei Pharmaceutical Co., Ltd. profitability indicators Graph chart: Hunan Liwin Group Liwei Pharmaceutical Co., Ltd. and liabilities charts: Hunan Liwin Group Liwei Pharmaceutical Co., Ltd. liabilities indicators Graph chart: Hunan Liwei Liwei Pharmaceutical Co., Ltd. operational capability indicators Graph chart: Hunan Li Wei Li Wei Pharmaceutical Co., Ltd. the ability to grow indicators Graph chart :2013-2018 Chinese anti-inflammatory drugs industry market trend analysis chart :2013-2018 anti-inflammatory drugs industry market earnings forecasts chart: Slightly ......